The Society for Immunotherapy of Cancer Announces Late-Breaking Abstracts and Press Briefing Presented at 38th Annual Meeting
MILWAUKEE, Oct. 25, 2023 /PRNewswire-PRWeb/ -- The Society for Immunotherapy of Cancer (SITC) received a record-breaking number of abstract submissions in 2023, more than 1,600, and has announced titles and authors for 30 accepted Late-breaking Abstracts (LBA). The abstracts will be presented at SITC's upcoming 38th Annual Meeting & Pre-Conference Programs taking place November 1–5, 2023, in San Diego, CA and virtually.
- The abstracts will be presented at SITC's upcoming 38th Annual Meeting & Pre-Conference Programs taking place November 1–5, 2023, in San Diego, CA and virtually.
- SITC also invites you to attend the virtual press briefing of the society's 38th Annual Meeting (SITC 2023) beginning at 12:00 p.m. PDT on Wednesday, Nov. 1, 2023.
- The abstracts will be presented at SITC's upcoming 38th Annual Meeting & Pre-Conference Programs taking place November 1–5, 2023, in San Diego, CA and virtually.
- The abstracts selected for the press briefing represent an array of the top advances in cancer immunotherapy research.